Skip to content

Thrombin Generation and Gestational Outcome

Thrombin Generation and Gestational Outcome in Women With Recurrent Pregnancy Loss

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02139670
Enrollment
29
Registered
2014-05-15
Start date
2013-10-31
Completion date
2017-12-31
Last updated
2018-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombophilia

Brief summary

In total 120 pregnant women's with history of recurrent miscarriages, are planned for inclusion in this trial. After signing an informed consent a blood sample will be obtained from each participant. The investigators will measure the thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT). The relation between pregnancy outcome and thrombin measurements will be determined

Interventions

None listed

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 18 * signed inform consent * first trimester * two early miscarriages(before week 10) or one later abortions (after week 10)

Exclusion criteria

* Chronic treatment with aspirin or other anticoagulants

Design outcomes

Primary

MeasureTime frame
pregnancy outcome2 years

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026